The multidisciplinary management of menopausal symptoms after breast cancer: A unique model of care

Menopause

Volumn 17, Issue 4, 2010, Pages 727-733

  Hickey, Martha ^a   Emery, Laura I ^b   Gregson, Jane ^a   Doherty, Dorota A ^a   Saunders, Christobel M ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Breast cancer; Menopause; Multidisciplinary management; Quality of life; Vasomotor symptoms

Indexed keywords

AGENTS USED INTRAVAGINALLY; ALPHA TOCOPHEROL; CLONIDINE; ESTROGEN; GABAPENTIN; HYPNOTIC AGENT; TIBOLONE; UNCLASSIFIED DRUG; VAGINAL MOISTURIZER; VENLAFAXINE; 4 AMINOBUTYRIC ACID; ADRENERGIC RECEPTOR BLOCKING AGENT; AMINE; ANXIOLYTIC AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; CYCLOHEXANOL DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; VITAMIN;

ADULT; AGED; ARTICLE; BREAST CANCER; DISEASE SEVERITY; FATIGUE; FEMALE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; NIGHT SWEAT; OVARY INSUFFICIENCY; SEXUAL DYSFUNCTION; SLEEP DISORDER; VAGINAL DRYNESS; VASOMOTOR DISORDER; BREAST TUMOR; HOT FLASHES; LIBIDO; MENOPAUSE; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT EDUCATION; PATIENT REFERRAL; PATIENT SATISFACTION; PHYSIOLOGY; PRACTICE GUIDELINE; SLEEP DISORDERS; SWEATING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; AMINES; ANTI-ANXIETY AGENTS; BREAST NEOPLASMS; CLONIDINE; CYCLOHEXANECARBOXYLIC ACIDS; CYCLOHEXANOLS; FATIGUE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS; LIBIDO; MENOPAUSE; MIDDLE AGED; PATIENT CARE TEAM; PATIENT EDUCATION AS TOPIC; PATIENT SATISFACTION; PATIENT-CENTERED CARE; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; SEROTONIN UPTAKE INHIBITORS; SLEEP DISORDERS; SWEATING; SYMPATHOLYTICS; VITAMIN E; VITAMINS;

EID: 77954953564     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181d672f6     Document Type: Article

References (51)

1. National Cancer Institute. Accessed October 2008. Available at: www. cancercontrol.cancer.gov/ocs/.
2. Hickey M, Saunders CM, Partridge A, Santoro N, Joffe H, Stearns V. Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol 2008;19:1669-1680.
3. Fellowes D, Fallowfield LJ, Saunders CM, Houghton J. Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for Fwell-tolerated' treatments? Breast Cancer Res Treat 2001;66:73-81
4. NIH state-of-the-science conference statement on management of menopause-related symptoms. NIH Consens State Sci Statements 2005; 22:1-38.
5. Bordeleau L, Pritchard K, Goodwin P, Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clin Ther 2007;29:230-241.
6. Thewes B, Meiser B, Rickard J, Friedlander M. The fertility and menopause-related information needs of younger women with a diagnosis of breast cancer: a qualitative study. Psychooncology 2003;12:500-511.
7. Antoine C, Liebens F, Carly B, Pastijn A, Rozenberg S. Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review. Climacteric 2007;10:23-26.
8. Fleissig A, Jenkins V, Catt S, Fallowfield L. Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol 2006;7:935-943.
9. Studdert D. Can liability rules keep pace with best practice? The case of multidisciplinary cancer care. Med J Aust 2008;188:380-381.
10. Multidisciplinary Cancer Care (MDC). Accessed 2008. Available at: www. nbocc.org.au/bestpractice/mdc/.
11. Greene JG. Constructing a standard climacteric scale. Maturitas 1998; 29:25-31.
12. Stearns V, Schneider B, Henry NL, Hayes DF, Flockhart DA. Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants. Nat Rev Cancer 2006;6:886-893.
13. Hickey M, Saunders CM, Stuckey BG. Management of menopausal symptoms in patients with breast cancer: an evidence-based approach. Lancet Oncol 2005;6:687-695.
14. Rebbeck T, Friebel T, Wagner T, et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral pro-phylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2005;23:7804-7810.
15. O'Neill S, MacLennan A, Bass S, et al. Guidelines for the management of postmenopausal osteoporosis for GPs. Aust Fam Physician 2004;33: 910-917.
16. Nedrow A, Miller J, Walker M, Nygren P, Hoyt Huffman L, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006;166:1453-1465.
17. McAndrew LM, Napolitano MA, Albrecht A, Farrell NC, Marcus BH, Whiteley JA. When, why and for whom there is a relationship between physical activity and menopause symptoms. Maturitas 2009;64:119-125.
18. Rogers CJ, Colbert LH, Greiner JW, Perkins SN, Hursting SD. Physical activity and cancer prevention: pathways and targets for intervention. Sports Med 2008;38:271-296.
19. McTiernan A. Mechanisms linking physical activity with cancer. Nat Rev Cancer 2008;8:205-211
20. The Jean Hailes Foundation for Women's Health. Available at: www. jeanhailes.org.au/. Accessed 2009.
21. AstraZeneca Academy. Available at: www.azacademy.com.au/. Accessed 2008
22. The Australasian Menopause Society. Available at: www.menopause. org.au. Accessed 2008.
23. National Breast and Ovarian Cancer Centre. Breast Cancer and Early MenopauseVA Guide For Younger Women. Surry Hills, NSW: National Breast and Ovarian Cancer Centre, 2008.
24. Holmberg L, Iversen OE, Rudenstam CM, et al. Increased risk of recur-rence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst 2008;100:475-482.
25. Rippy L, Marsden J. Is HRT justified for symptom management in women at higher risk of developing breast cancer? Climacteric 2006;9: 404-415.
26. Kendall A, Dowsett M, Folkerd E, Smith I. Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 2006;17:584-587.
27. Spilsbury K, Semmens JB, Saunders CM, Holman CDJ. Long-term survival outcomes following breast cancer surgery in Western Australia. ANZ J Surg 2005;75:625-630.
28. Mitchell KJ, Fritschi L, Reida A, et al. Rural-urban differences in the presentation, management and survival of breast cancer in Western Australia. Breast 2006;15:769-776.
29. Thirlaway K, Fallowfield L, Cuzick J. The Sexual Activity Question-naire: a measure of women's sexual functioning. Qual Life Res 1996;5: 81-90.
30. Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat 1999;55:189-199.
31. Benshushan A, Rojansky N, Chaviv M, et al. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy. Climacteric 2009;12:404-409.
32. Chattha R, Kulkarni R, Nagarathna R, Nagendra HR. Factor analysis of Greene's Climacteric Scale for Indian women. Maturitas 2008;59:22-27.
33. Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007 [review]. J Exp Clin Cancer Res 2008;27:32.
34. Kenemans K, Bundred NJ, Foidart J, et al. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol 2009;10:135-146.
35. von Schoultz E, Rutqvist LE. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial. J Natl Cancer Inst 2005;97: 533-535.
36. Politi MC, Schleinitz MD, Col NF. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med 2008;23: 1507-1513.
37. Fallowfield LJ. Quality of life measurement in breast cancer. J R Soc Med 1993;86:10-12.
38. Frey BN, Lord C, Soares CN. Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates. Menopause Int 2008;14:123-128.
39. Buijs C, Mom C, Willemse P, et al. Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, ran-domized cross-over study. Breast Cancer Res Treat 2009;115:573-580.
40. Reddy S, Warner H, Guttuso T, et al. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 2006;108:41-48.
41. Barentsen R, van de Weijer PH, Schram JH. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 1997;71:73-80.
42. Holmberg L, Anderson H, HABITS Steering Data Monitoring Commit-tees. HABITS (hormonal replacement therapy after breast cancerYis it safe?), a randomised comparison. Lancet 2004;363:453-455.
43. Ness J, Aronow WS, Beck G. Menopausal symptoms after cessation of hormone replacement therapy. Maturitas 2006;53:356-361.
44. Cuzick J, Sestak I, Cella D, Fallowfield L. Treatment-emergent endo-crine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol 2008;9:1143-1148.
45. National Breast Cancer Centre. What is multidisciplinary care? 2005. Available at www.nbocc.org.au. Accessed 2009.
46. Lanceley A, Savage J, Menon U, Jacobs I. Influences on multidisci-plinary team decision-making. Int J Gynecol Cancer 2008;18:215-222.
47. Zorbas H, Barraclough B, Rainbird K, Luxford K, Redman S. Multi-disciplinary care for women with early breast cancer in the Australian context: what does it mean? Med J Aust 2003;179:528-531.
48. Gabel M, Hilton NE, Nathanson SD. Multidisciplinary breast cancer clinics: do they work? Cancer 1997;79:2380-2384.
49. Wolf L. The information needs of women who have undergone breast reconstruction. Part I: decision-making and sources of information. Eur J Oncol Nurs 2004;8:211-223. (Pubitemid 39145141)
50. Wolf L. The information needs of women who have undergone breast reconstruction. Part II: Information giving and content of information. Eur J Oncol Nurs 2004;8:315-324. (Pubitemid 39517060)
51. Sandelin K, King E, Redman S. Breast reconstruction following mastec-tomy: current status in Australia. ANZ J Surg 2003;73:701-706.